Eben I. Lichtman

835 citations
30 papers · 626 indexed · h-index 8
Topics
Multiple Myeloma Research and Treatments (13 papers)Monoclonal and Polyclonal Antibodies Research (5 papers)CAR-T cell therapy research (4 papers)

In The Last Decade

Eben I. Lichtman

27 papers receiving 614 citations

Peers

Eben I. Lichtman
Comparison fields: 5 of 87
  • Molecular Biology 292
  • Oncology 266
  • Immunology 121
  • Hematology 117
  • Epidemiology 58
Replace Nicole Ng with:
Nicole Ng United States
Shripad Sinari United States
Thomas Gelzleichter United States
Christophe Badie United Kingdom
Xianfeng Zha China
Takashi Shinya Japan
Shinya Fujisawa Japan
Akihisa Suzuki Japan
Sílvia Xargay‐Torrent Spain
Yawei Qiao United States
Eben I. Lichtman relative to Nicole Ng United States Nicole Ng's profile →
Citations per field
00.5×6.4×
Nicole Ng · 1×
Citations per year

Countries citing papers authored by Eben I. Lichtman

Since Specialization
Citations

This map shows the geographic impact of Eben I. Lichtman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eben I. Lichtman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eben I. Lichtman more than expected).

Fields of papers citing papers by Eben I. Lichtman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eben I. Lichtman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eben I. Lichtman. The network helps show where Eben I. Lichtman may publish in the future.

Co-authorship network of co-authors of Eben I. Lichtman

This figure shows the co-authorship network connecting the top 25 collaborators of Eben I. Lichtman. A scholar is included among the top collaborators of Eben I. Lichtman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eben I. Lichtman. Eben I. Lichtman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 2
5 3
6 6
7 6
8 6
9 6
10 57
11 18
12 4
13 77
14 19
15 5
16 34
17 67
18 1
19 71
20 220

About Eben I. Lichtman

Eben I. Lichtman is a scholar working on Hematology, Genetics and Geriatrics and Gerontology, having authored 30 papers that have together received 626 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (13 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Hematology (117 citations), Oncology (266 citations) and Immunology (121 citations). Eben I. Lichtman has collaborated with scholars based in United States, Australia and Czechia. Frequent co-authors include Benedikt M. Kessler, Paul J. Galardy, Kenneth C. Anderson, Huib Ovaa, Celia R. Berkers, Hidde L. Ploegh, Martijn Verdoes, Edda Fiebiger, Martin Kriegel and Gianpietro Dotti. Their work appears in journals such as Journal of Clinical Oncology, Blood and Nature Methods.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026